McCluggage W Glenn, Judge Meagan J, Alvarado-Cabrero Isabel, Duggan Máire A, Horn Lars-Christian, Hui Pei, Ordi Jaume, Otis Christopher N, Park Kay J, Plante Marie, Stewart Colin J R, Wiredu Edwin K, Rous Brian, Hirschowitz Lynn
Department of Pathology, Belfast Health and Social Care Trust, Belfast and Chair of the ICCR Cervical Carcinoma Panel (W.G.M.) Department of Histopathology, Addenbrookes Hospital, Cambridge and ICCR Steering Group Representative (B.R.) Department of Cellular Pathology, Birmingham Women's Hospital, Birmingham and ICCR Steering Group Representative (L.H.), UK Royal College of Pathologists of Australasia, Sydney, NSW (M.J.J.) Department of Histopathology, King Edward Memorial Hospital, Perth, WA (C.J.R.S.), Australia Department of Pathology, Mexican Oncology Hospital, IMSS, Mexico City, Mexico (I.A.C.) Department of Pathology and Laboratory Medicine, University of Calgary, AB (M.A.D.) Gynecologic Oncology Service, Centre Hospitalier Universitaire de Québec, L'Hôtel-Dieu de Québec, Laval University, QC (M.P.), Canada Division of Gynecologic, Breast & Perinatal Pathology,University Hospital Leipzig, Germany (L.C.H.) Department of Pathology, Yale University School of Medicine, New Haven, CT (P.H.) ISGlobal, Barcelona Centre for International Health Research (CRESIB), Hospital Clinic of Barcelona, Universitat de Barcelona, Barcelona, Spain (J.O.) Department of Pathology, University of Massachusetts Medical Center-Baystate Health, Springfield, MA (C.N.O.) Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY (K.J.P.) Department of Pathology, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Ghana (E.K.W.).
Int J Gynecol Pathol. 2018 May;37(3):205-228. doi: 10.1097/PGP.0000000000000412.
A comprehensive pathologic report is essential for optimal patient management, cancer staging and prognostication. In many countries, proforma reports are used but the content of these is variable. The International Collaboration on Cancer Reporting is an alliance formed by the Royal Colleges of Pathologists of Australasia and the United Kingdom, the College of American Pathologists, the Canadian Partnership Against Cancer and the European Society of Pathology, for the purpose of developing standardized, evidence-based reporting data sets for each cancer site. This will reduce the global burden of cancer data set development and reduplication of effort by different international institutions that commission, publish and maintain standardized cancer-reporting data sets. The resultant standardization of cancer-reporting benefits not only those countries directly involved in the collaboration but also others not in a position to develop their own data sets. We describe the development of an evidence-based cancer data set by the International Collaboration on Cancer Reporting expert panel for the reporting of primary cervical carcinomas and present the "required" and "recommended" elements to be included in the pathology report as well as an explanatory commentary. This data set encompasses the International Federation of Obstetricians and Gynaecologists and Union for International Cancer Control staging systems for cervical neoplasms and the updated World Health Organization classification of gynecologic tumors. The data set also addresses controversial issues such as tumor grading and measurement, including measurement of multifocal carcinomas. The widespread implementation of this data set will facilitate consistent and accurate data collection, comparison of epidemiological and pathologic parameters between different populations, facilitate research, and hopefully result in improved patient management.
一份全面的病理报告对于优化患者管理、癌症分期和预后判断至关重要。在许多国家，使用了格式报告，但其内容各不相同。癌症报告国际协作组织是由澳大拉西亚皇家病理学家学院、英国皇家病理学家学院、美国病理学家学会、加拿大抗癌伙伴组织和欧洲病理学会组成的联盟，旨在为每个癌症部位制定标准化的、基于证据的报告数据集。这将减轻全球癌症数据集开发的负担，并减少不同国际机构在委托、发布和维护标准化癌症报告数据集方面的重复工作。由此产生的癌症报告标准化不仅有利于直接参与协作的国家，也有利于那些无法自行开发数据集的国家。我们描述了癌症报告国际协作组织专家小组为原发性宫颈癌报告制定基于证据的癌症数据集的过程，并列出了病理报告中应包含的“必需”和“推荐”要素以及解释性评论。该数据集涵盖了国际妇产科联合会和国际癌症控制联盟的宫颈癌分期系统以及世界卫生组织更新的妇科肿瘤分类。该数据集还涉及肿瘤分级和测量等有争议的问题，包括多灶性癌的测量。该数据集的广泛实施将有助于进行一致且准确的数据收集，便于比较不同人群之间的流行病学和病理参数，促进研究，并有望改善患者管理。
